Thus, peripheral inflammation associated with i.p. administration of LPS in 3xTgAD mice [48], as well as central inflammation induced by intracerebroventricular (i.c.v.)administration of LPS in a mouse model of tauopathy [49], have been shown to augment tau-phosphorylation in the brain. This evidence concerns the gene MAPT and tauopathy.